Human Engineered Heart Tissue: Analysis of Contractile Force

Ingra Mannhardt(Universität Hamburg), Kaja Breckwoldt(Universität Hamburg), David Letuffe-Brenière(Universität Hamburg), Sebastian Schaaf(Universität Hamburg), Herbert Schulz(University of Cologne), Christiane Neuber(Universität Hamburg), Anika Benzin(Universität Hamburg), Tessa Werner(Universität Hamburg), Alexandra Eder(Universität Hamburg), Thomas G. Schulze(Universität Hamburg), Birgit Klampe(Universität Hamburg), Torsten Christ(Universität Hamburg), Marc N. Hirt(Universität Hamburg), Norbert Huebner(Max Delbrück Center), Alessandra Moretti(TUM Klinikum), Thomas Eschenhagen(Universität Hamburg), Arne Hansen(Universität Hamburg)
Stem Cell Reports
May 21, 2016
Cited by 382Open Access
Full Text

Abstract

Analyzing contractile force, the most important and best understood function of cardiomyocytes in vivo is not established in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM). This study describes the generation of 3D, strip-format, force-generating engineered heart tissues (EHT) from hiPSC-CM and their physiological and pharmacological properties. CM were differentiated from hiPSC by a growth factor-based three-stage protocol. EHTs were generated and analyzed histologically and functionally. HiPSC-CM in EHTs showed well-developed sarcomeric organization and alignment, and frequent mitochondria. Systematic contractility analysis (26 concentration-response curves) reveals that EHTs replicated canonical response to physiological and pharmacological regulators of inotropy, membrane- and calcium-clock mediators of pacemaking, modulators of ion-channel currents, and proarrhythmic compounds with unprecedented precision. The analysis demonstrates a high degree of similarity between hiPSC-CM in EHT format and native human heart tissue, indicating that human EHTs are useful for preclinical drug testing and disease modeling.


Related Papers

No related papers found

Powered by citation graph analysis